Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Adrian Kielhorn
ResearcherPublications, citations & collaboration network
Adrian Kielhorn is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 111 works, 862 citations, an h-index of 16 and an i10-index of 20.
111
Works
862
Citations
16
h-index
20
i10-index
IDs:OpenAlex
How has Adrian Kielhorn's publication output changed over time?
ScholarIQpublication output · 1996–2021
Output grew100% over the shown period — from 1 works in 1996 to 2 in 2021.
1
1
1
1
1
2
1
1
2
199620032008200920102016201720202021
What are the most-cited papers on Adrian Kielhorn?
ScholarIQmost cited works
Economic burden of hospitalizations of Medicare beneficiaries with heart failure
Meredith L. Kilgore, Harshali Patel, Adrian Kielhorn, Juan Maya, Pradeep Sharma
S2764962273. 2017155 CitationsOPEN ACCESS
Indirect Comparison of Tocilizumab and Other Biologic Agents in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs
Gert Bergman, Marc C. Hochberg, Maarten Boers, Neil Wintfeld, Adrian Kielhorn, Jeroen P. Jansen
Seminars in Arthritis and Rheumatism. 2010101 Citations
UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug
Adrian Kielhorn, Duncan Porter, Α. Διαμαντόπουλος, Gavin Lewis
Current Medical Research and Opinion. 200858 Citations
Neuromyelitis Optica Spectrum Disorder: Clinical Burden and Cost of Relapses and Disease-Related Care in US Clinical Practice
Minying Royston, Adrian Kielhorn, Derek Weycker, Melody Shaff, Linnea Houde, Imran Tanvir, Shamik Bhattacharyya, Michael Levy
S2736361170. 202146 CitationsOPEN ACCESS
Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe
Joan H. Schiller, Dominic Tilden, M Aristides, Michael Lees, Adrian Kielhorn, Nikos Maniadakis, Shkun Bhalla
Lung Cancer. 200345 Citations
Related on ScholarIQ
AstraZeneca (Brazil)
Institution
Economic burden of hospitalizations of Medicare beneficiaries with heart failure
Paper
Indirect Comparison of Tocilizumab and Other Biologic Agents in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs
Paper
UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug
Paper
Neuromyelitis Optica Spectrum Disorder: Clinical Burden and Cost of Relapses and Disease-Related Care in US Clinical Practice
Paper
Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe
Paper